Magnesium Sulfate Crash Cart Use: Emergency Indications and Dosing Protocols
Torsades de Pointes
For torsades de pointes associated with acquired QT prolongation, administer IV magnesium sulfate 1-2 g as a bolus over 5 minutes, even if serum magnesium is normal. 1
- This is a Class I recommendation for cardiotoxicity and cardiac arrest from severe hypomagnesemia or drug-induced torsades 2, 1
- Magnesium suppresses episodes of torsades without necessarily shortening the QT interval 3
- For recurrent torsades that cannot be suppressed with IV magnesium, increase heart rate with atrial/ventricular pacing or isoproterenol 4
- Maintain potassium ≥4.0-4.5 mmol/L and magnesium ≥2.0 mmol/L 4, 3
- Critical caveat: Magnesium has NOT been shown effective for polymorphic VT with normal QT interval 5
- The 2025 AHA guidelines confirm magnesium remains indicated only for torsades with long QT, not for routine ventricular arrhythmias 5
Severe Pre-eclampsia/Eclampsia
For severe pre-eclampsia with clinical signs of severity, administer a loading dose of 4-5 g IV over 3-4 minutes (or infused in 250 mL over 15-20 minutes), followed by maintenance of 1-2 g/hour by continuous infusion. 6
- Alternative loading: 4 g IV plus 10 g IM (5 g in each buttock), then 5 g IM every 4 hours 6
- Target serum magnesium level: 4.8-6 mg/dL (optimal for seizure control) 1, 6
- For obese women (BMI ≥35): Consider higher dosing—6 g IV loading dose followed by 2 g/hour maintenance, as standard Zuspan dosing achieves subtherapeutic levels in 100% of obese patients 7
- Monitor patellar reflexes and respiratory function before each dose 6
- Maximum dose: 30-40 g per 24 hours; in severe renal insufficiency, maximum 20 g per 48 hours 6
- Critical warning: Continuous use beyond 5-7 days in pregnancy can cause fetal abnormalities 6
Severe Refractory Asthma
For life-threatening asthma exacerbations that remain severe after 1 hour of intensive conventional treatment, consider IV magnesium sulfate 2 g (approximately 40 mEq) infused over 20 minutes. 8
- This is a conditional recommendation for patients failing standard therapy 8
- The National Asthma Education and Prevention Program states magnesium has "no apparent value" in lower severity exacerbations 8
- Pediatric dosing: 50 mg/kg over 1 hour (maximum 2 g) 9
- High-dose prolonged infusion (50 mg/kg/hour for 4 hours, max 8 g) shows superior efficacy in pediatric severe asthma, with 47% discharge rate at 24 hours versus 10% with bolus dosing 9
- Nebulized magnesium (isotonic solution) may provide additional benefit when combined with beta-agonists 10
Acute Symptomatic Hypomagnesemia
For severe hypomagnesemia with tetany or cardiac manifestations, administer 1-2 g (8-16 mEq) magnesium sulfate IV push over 5-15 minutes, followed by continuous infusion. 1, 6
- For mild deficiency: 1 g (8.12 mEq) IM every 6 hours for 4 doses 6
- For severe deficiency: Up to 250 mg/kg (approximately 2 mEq/kg) IM over 4 hours if necessary 6
- Alternative for severe cases: 5 g (40 mEq) in 1 L D5W or NS infused over 3 hours 6
- Caution: Do not exceed renal excretory capacity; monitor serum levels 6
Crash Cart Stocking Recommendations
Stock multiple 2 mL vials of 50% magnesium sulfate (1 g per 2 mL = 500 mg/mL) for immediate bolus administration. 6
- Pre-diluted solutions (10-20% concentration) should be available for slower infusions 6
- Maximum IV injection rate: 150 mg/minute (1.5 mL of 10% solution), except in severe eclampsia with seizures 6
- Solutions for IV infusion must be diluted to ≤20% concentration 6
- Store at room temperature (20-25°C); contains no preservative, discard unused portions 6
Critical Safety Monitoring
- Monitor for magnesium toxicity: Loss of patellar reflexes (8-12 mg/dL), respiratory depression (12-15 mg/dL), cardiac arrest (>15 mg/dL) 1
- Have calcium gluconate 10% (15-30 mL IV) or calcium chloride 10% (5-10 mL IV) immediately available as antidote for hypermagnesemia 1
- In cardiac arrest from suspected hypermagnesemia, empirical IV calcium may be reasonable 2
Common Pitfalls to Avoid
- Do NOT use magnesium for routine cardiac arrest—multiple RCTs show no benefit for undifferentiated arrest or VF/VT without long QT 11
- Do NOT use magnesium for polymorphic VT with normal QT—this is typically ischemia-driven and requires different management 5
- Do NOT give bolus potassium for cardiac arrest in suspected hypokalemia—this is potentially harmful (Class III: Harm) 2, 1
- Do NOT continue magnesium in pregnancy beyond 5-7 days—risk of fetal skeletal abnormalities 6